Cancer Treatment

Immunotherapy Drug Development Innovative Therapies Radiation Therapy Leukemia Pancreatic Cancer Nanotechnology Targeted Therapy Pharmaceuticals Therapies

3 ARTICLES

2w ago

14-Protein Blood Test Predicts Lung Cancer Risk Years Before Diagnosis

Mechanistic work linking the proteins to pollution-driven IL-1β inflammation points to the possibility that targeted IL-1β blockade could lower lung cancer risk

6 ARTICLES

2w ago

J. Craig Venter, Pioneering Genomicist Who Raced to Decode Human DNA, Dies at 79

4 ARTICLES

2mo ago

New Study Explains Why BET Drugs Falter by Splitting BRD2 and BRD4 Roles

4 ARTICLES

3mo ago

TerraPower Isotopes Chooses Philadelphia's Bellwether District for $450 Million Actinium-225 Plant

6 ARTICLES

3mo ago

Waterloo Scientists Ready Engineered Tumor‑Eating Bacteria for Preclinical Testing

3 ARTICLES

3mo ago

New Single-Particle Assay Finds Disordered Lipid Nanoparticles Release RNA More Effectively

6 ARTICLES

4mo ago

Fujifilm Opens £400m Billingham Expansion, Creating the UK’s Largest Single‑Use Biologics CDMO

4 ARTICLES

4mo ago

Brookhaven Shuts RHIC After Final Collision as DOE Approves Electron-Ion Collider

6 ARTICLES

4mo ago

Moderna, Merck Melanoma Vaccine Shows Durable Five-Year Benefit as Stock Hits 52-Week High

8 ARTICLES

5mo ago

Immune Atlas Sharpens Myeloma Risk Prediction as Dual-Target CAR T Counters BCMA Loss

4 ARTICLES

5mo ago

Antiques Roadshow's Theo Burrell Says Scans Are Clear, Will Attempt Next Chemo Cycle Despite Setbacks

7 ARTICLES

5mo ago

Cypherpunk Lifts Zcash Treasury to 290,062.67 ZEC With $29 Million Buy

4 ARTICLES

5mo ago

RMIT Engineers Nanodots That Kill Cancer Cells in Lab Tests While Largely Sparing Healthy Cells

3 ARTICLES

7mo ago

2025 Tata Transformation Prize Honors Three Indian Scientists Advancing Food Security, Sustainability, and Healthcare

5 ARTICLES

7mo ago

mRNA COVID Vaccines Tied to Longer Survival With Checkpoint Immunotherapy, Nature Study Reports

7 ARTICLES

8mo ago

Google and Yale Release 27B-Parameter Cell AI After Lab Confirms Interferon-Conditional Antigen Boost

8 ARTICLES

8mo ago

Nature Papers Identify RHOG and CDKN1B as In Vivo Boosters for CAR T Cells

Cancer Treatment

14-Protein Blood Test Predicts Lung Cancer Risk Years Before Diagnosis

White House Rule Would Put Political Appointees in Charge of Federal Grants

CRISPR Enzyme Cas12a2 Selectively Destroys Cells Based on RNA in Lab Tests

New CAR-T Designs Deliver Low-Dose Remissions and Expose a Senescence Risk

J. Craig Venter, Pioneering Genomicist Who Raced to Decode Human DNA, Dies at 79

New Study Explains Why BET Drugs Falter by Splitting BRD2 and BRD4 Roles

TerraPower Isotopes Chooses Philadelphia's Bellwether District for $450 Million Actinium-225 Plant

Waterloo Scientists Ready Engineered Tumor‑Eating Bacteria for Preclinical Testing

New Single-Particle Assay Finds Disordered Lipid Nanoparticles Release RNA More Effectively

Fujifilm Opens £400m Billingham Expansion, Creating the UK’s Largest Single‑Use Biologics CDMO

Never miss stories about

Cancer Treatment

Brookhaven Shuts RHIC After Final Collision as DOE Approves Electron-Ion Collider

Moderna, Merck Melanoma Vaccine Shows Durable Five-Year Benefit as Stock Hits 52-Week High

Immune Atlas Sharpens Myeloma Risk Prediction as Dual-Target CAR T Counters BCMA Loss

Antiques Roadshow's Theo Burrell Says Scans Are Clear, Will Attempt Next Chemo Cycle Despite Setbacks

Cypherpunk Lifts Zcash Treasury to 290,062.67 ZEC With $29 Million Buy

RMIT Engineers Nanodots That Kill Cancer Cells in Lab Tests While Largely Sparing Healthy Cells

2025 Tata Transformation Prize Honors Three Indian Scientists Advancing Food Security, Sustainability, and Healthcare

mRNA COVID Vaccines Tied to Longer Survival With Checkpoint Immunotherapy, Nature Study Reports

Google and Yale Release 27B-Parameter Cell AI After Lab Confirms Interferon-Conditional Antigen Boost

Nature Papers Identify RHOG and CDKN1B as In Vivo Boosters for CAR T Cells

Never miss stories about

Cancer Treatment